Anti‐CRISPR Protein Regulates CRISPR/Cas12a Fusogenic‐Nanovesicle‐Based Platform for Extracellular Vesicle‐Encapsulated Non‐Nucleic Acid Target In‐Vesicle Detection
Angewandte Chemie International Edition · 22.06.2026 · 65 (26)
DOI: 10.1002/anie.6795217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 07.05.2026. Verfasst von Qiaoxuan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine/State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou Universi…. Hauptthemen laut MEDLINE: Extracellular Vesicles, CRISPR-Cas Systems, CRISPR-Associated Proteins, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Guangdong Special Support Program Health and health talents List Project of Provincial Health Commission, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
The detection of non‐nucleic acid targets encapsulated in extracellular vesicles (EVs) faces two major challenges: (1) difficulties in efficient isolation and the risk of content degradation, and (2) the low abundance of target molecules encapsulated in EVs always leads to failed signal transduction and inadequate output signal intensity. To overcome these limitations, we propose a high‐efficiency in‐vesicle analysis strategy that integrates targeting probe delivery and regulation by protein signal amplification. By applying aptamer‐mediated membrane fusion and “locked‐activated” CRISPR‐Cas12a‐AcrVA1 (LACA) for protein signal regulation, we fabricated a yly12‐aptamer‐functionalized self‐assembled nanovesicle which encapsulate LACA‐system (yly12‐lipo@Cas12a nanovesicle) as an in‐vesicle bioanalytical platform. Leveraging the high specificity of the aptamer and the regulatory function of AcrVA1 in selectively modulating Cas12a activity, the platform enables highly specifiec and sensitive detection, offering advantages of simple operation and versatility across platforms within only 2.5 h. Clinical analysis demonstrated effective differentiation between patients and healthy controls, yielding high diagnostic performance with an AUC of 0.965. The proposed platform shows great potential for EV‐carrying protein biomarker analysis and has broad prospects for the disease's diagnosis in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine/State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Draggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and In…
ORCID-Profile: Qiaoxuan Zhang, Liqiao Han, Ting Liu, Qiqin Wang, Xianzhang Huang
Förderung
- National Key Research and Development Program of China
- Guangdong Special Support Program Health and health talents List Project of Provincial Health Commission
- Natural Science Foundation of Guangdong Province
- "Young Talents Program" of Guangdong Academy of Traditional Chinese Medicine
- State Key Laboratory of Traditional Chinese Medicine Syndrome Projects
- Guangzhou Science and Technology Plan Projects
- Guangdong Provincial Clinical Research Guangdong Provincial Clinical Research Center for Laboratory Medicine
- Science and Technology Innovation Center of Guangzhou University of Chinese Medicine
Zitieren
APA
Zhang, Q., Li, Y., Li, Y., Han, L., Yan, J., Zhan, M., Liu, T., Ke, P., Wang, Q., & Huang, X. (2026). Anti‐CRISPR Protein Regulates CRISPR/Cas12a Fusogenic‐Nanovesicle‐Based Platform for Extracellular Vesicle‐Encapsulated Non‐Nucleic Acid Target In‐Vesicle Detection. Angewandte Chemie International Edition, 65(26). https://doi.org/10.1002/anie.6795217
Vancouver
Zhang Q, Li Y, Li Y, Han L, Yan J, Zhan M, et al. Anti‐CRISPR Protein Regulates CRISPR/Cas12a Fusogenic‐Nanovesicle‐Based Platform for Extracellular Vesicle‐Encapsulated Non‐Nucleic Acid Target In‐Vesicle Detection. Angewandte Chemie International Edition. 2026;65(26). doi:10.1002/anie.6795217
BibTeX
@article{Zhang2026,
author = {Zhang, Qiaoxuan and Li, Yaling and Li, Yuanzhe and Han, Liqiao and Yan, Jun and Zhan, Min and Liu, Ting and Ke, Peifeng and Wang, Qiqin and Huang, Xianzhang},
title = {Anti‐CRISPR Protein Regulates CRISPR/Cas12a Fusogenic‐Nanovesicle‐Based Platform for Extracellular Vesicle‐Encapsulated Non‐Nucleic Acid Target In‐Vesicle Detection},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {26},
doi = {10.1002/anie.6795217}
}
EUVIMED